Hanamura, Toru
Kitano, Shigehisa
Kagamu, Hiroshi
Yamashita, Makiko
Terao, Mayako
Okamura, Takuho
Kumaki, Nobue
Hozumi, Katsuto
Iwamoto, Takayuki
Honda, Chikako
Kurozumi, Sasagu
Niikura, Naoki
Funding for this research was provided by:
Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (20K22856, 18K16266)
The 2021 Tokai University School of Medicine Research Aid
Chugai Pharmaceutical Co. Ltd.
Article History
Received: 11 July 2022
Accepted: 17 January 2023
First Online: 31 January 2023
Change Date: 20 March 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s13058-023-01637-0
Declarations
:
: This study was conducted at Tokai University Hospital and approved by the Ethics Committee, which conforms to the provisions of the Declaration of Helsinki (Accepted project No. 16R-279 and 20R-049). Patients were enrolled from May 2015 to April 2019, and written informed consent was obtained from all the patients to publish this paper.
: Not applicable.
: Hiroshi Kagamu has an advisory role in ImmuniT Research Inc, received honoraria from AstraZeneca K.K., Ono Pharmaceutical Co. Ltd., and Bristol-Myers Squibb Co. Ltd. Shigehisa Kitano received honoraria from Ono Pharmaceutical Co., Bristol-Myers Squibb Co., Ltd., AstraZeneca K.K., Chugai Pharmaceutical Co., Ltd., Pfizer Japan Inc., and MSD Co. Ltd, received research funding from Astellas Pharma Inc., Gilead Sciences Inc., Eisai Co., Ltd., Regeneron Pharmaceuticals Inc., Boehringer Ingelheim GmbH, Daiichi Sankyo Co., Ltd., Ono Pharmaceutical Co., Takara Bio Inc., PACT Pharma Inc., Chugai Pharmaceutical Co., Ltd., and MSD Co., Ltd. Naoki Niikura received honoraria from AstraZeneca K.K., Daiichi Sankyo Co. Ltd., Pfizer Japan Inc., Eisai Co. Ltd., and Nippon Kayaku Co. Ltd. Sasagu Kurozumi has received honoraria from Eli Lilly and Company, Daiichi Sankyo co. ltd, Taiho Pharmaceutical co. ltd, MSD K.K., AstraZeneca K.K., Chugai Pharmaceutical, Ltd., Dinow Inc., Eisai Co., Ltd. and Novartis Japan. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.